A Study to Determine the Bioavailability of Lanadelumab (SHP643) Administered Subcutaneously With the Prefilled Syringe and the Autoinjector in Healthy Adult Volunteer Participants.
Clinical trial NCT03918239 · COMPLETED
Trial details
- NCT number
- NCT03918239
- Sponsor
- Shire
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-14
- Primary completion
- 2019-11-13
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.